Significance of Temporal Muscle Thickness in Chronic Subdural Hematoma

ORCID
0000-0001-5568-8429
Zugehörigkeit
Department of Neurosurgery, Rostock University Medical Center, 18057 Rostock, Germany
Dubinski, Daniel;
Zugehörigkeit
Department of Neurosurgery, Rostock University Medical Center, 18057 Rostock, Germany
Won, Sae-Yeon;
Zugehörigkeit
Department of Neurosurgery, Rostock University Medical Center, 18057 Rostock, Germany
Behmanesh, Bedjan;
Zugehörigkeit
Institute of Diagnostic and Interventional Radiology, Pediatric Radiology and Neuroradiology, Rostock University Medical Center, 18057 Rostock, Germany
Cantré, Daniel;
Zugehörigkeit
Department of Neurosurgery, Rostock University Medical Center, 18057 Rostock, Germany
Mattes, Isabell;
Zugehörigkeit
Department of Neurosurgery, Rostock University Medical Center, 18057 Rostock, Germany
Trnovec, Svorad;
GND
105011048X
ORCID
0000-0002-2563-2691
Zugehörigkeit
Department of Neurosurgery, University Hospital, Schiller University Jena, 07747 Jena, Germany
Baumgarten, Peter;
ORCID
0000-0002-5806-2576
Zugehörigkeit
Department of Neurosurgery, Unfallkrankenhaus Berlin, 12683 Berlin, Germany
Schuss, Patrick;
ORCID
0000-0002-2591-2829
Zugehörigkeit
Department of Neurosurgery, Rostock University Medical Center, 18057 Rostock, Germany
Freiman, Thomas M.;
ORCID
0000-0002-3471-0575
Zugehörigkeit
Department of Neurosurgery, Rostock University Medical Center, 18057 Rostock, Germany
Gessler, Florian

Background: Reduced temporal muscle thickness (TMT) was verified as an independent negative prognostic parameter for outcome in brain tumor patients. Independent thereof, chronic subdural hematoma (CSDH) is a neurosurgical condition with high recurrence rates and unreliable risk models for poor outcome. Since sarcopenia was associated with poor outcome, we investigated the possible role of TMT and the clinical course of CSDH patients. Methods: This investigation is a single-center retrospective study on patients with CSDH. We analyzed the radiological and clinical data sets of 171 patients with surgically treated CSDH at a University Hospital from 2017 to 2020. Results: Our analysis showed a significant association between low-volume TMT and increased hematoma volume ( p < 0.001), poor outcome at discharge ( p < 0.001), and reduced performance status at 3 months ( p < 0.002). Conclusion: TMT may represent an objective prognostic parameter and assist the identification of vulnerable CSDH patients.

Zitieren

Zitierform:
Zitierform konnte nicht geladen werden.

Rechte

Rechteinhaber: © 2022 by the authors.

Nutzung und Vervielfältigung: